Skip to main content
. 2022 Jun 22;151(9):1447–1461. doi: 10.1002/ijc.34158

TABLE 2.

Global patterns of age‐specific incidence rate, male‐to‐female incidence rate ratios and 95% CIs for esophageal squamous cell carcinoma, esophageal adenocarcinoma, gastric cardia cancer and gastric noncardia cancer (2003‐2012)

Cancer type Age group Incidence rate per 100 000 in males (95% CIs) Incidence rate per 100 000 in females (95% CIs) Male‐to‐female incidence rate ratios (95% CIs)
Esophageal squamous cell carcinoma (ESCC) 20‐24 0.01 (0.01, 0.01) 0.01 (0.01, 0.01) 0.98 (0.57, 1.69)
25‐29 0.03 (0.02, 0.03) 0.02 (0.02, 0.03) 1.31 (0.93, 1.83)
30‐34 0.08 (0.07, 0.09) 0.06 (0.06, 0.07) 1.26 (1.04, 1.54)
35‐39 0.28 (0.26, 0.30) 0.14 (0.13, 0.16) 1.92 (1.70, 2.16)
40‐44 0.96 (0.92, 0.99) 0.37 (0.35, 0.39) 2.57 (2.40, 2.76)
45‐49 2.89 (2.82, 2.95) 0.80 (0.77, 0.83) 3.61 (3.44, 3.78)
50‐54 6.42 (6.32, 6.52) 1.74 (1.69, 1.79) 3.69 (3.57, 3.81)
55‐59 11.14 (11.00, 11.28) 2.94 (2.87, 3.01) 3.78 (3.68, 3.89)
60‐64 16.17 (15.99, 16.36) 4.24 (4.15, 4.34) 3.81 (3.72, 3.90)
65‐69 21.22 (20.98, 21.46) 5.86 (5.75, 5.98) 3.62 (3.54, 3.70)
70‐74 24.21 (23.93, 24.50) 7.60 (7.46, 7.75) 3.19 (3.12, 3.26)
75‐79 24.09 (23.77, 24.43) 9.06 (8.90, 9.24) 2.66 (2.60, 2.72)
80‐84 23.34 (22.93, 23.76) 10.90 (10.68, 11.12) 2.14 (2.09, 2.20)
85+ 21.53 (21.04, 22.03) 12.48 (12.24, 12.73) 1.72 (1.67, 1.78)
Esophageal adenocarcinoma (EAC) 20‐24 0.02 (0.01, 0.02) 0.01 (0.00, 0.01) 2.92 (1.61, 5.31)
25‐29 0.06 (0.05, 0.07) 0.01 (0.01, 0.01) 6.23 (4.08, 9.51)
30‐34 0.14 (0.12, 0.15) 0.03 (0.02, 0.04) 4.66 (3.67, 5.92)
35‐39 0.38 (0.36, 0.40) 0.07 (0.06, 0.08) 5.66 (4.84, 6.60)
40‐44 1.04 (1.00, 1.07) 0.16 (0.15, 0.18) 6.44 (5.84, 7.10)
45‐49 2.40 (2.34, 2.45) 0.32 (0.30, 0.34) 7.41 (6.92, 7.94)
50‐54 5.00 (4.91, 5.09) 0.62 (0.59, 0.65) 8.05 (7.64, 8.47)
55‐59 8.89 (8.76, 9.01) 1.11 (1.07, 1.15) 8.00 (7.68, 8.34)
60‐64 13.77 (13.60, 13.95) 1.72 (1.66, 1.78) 8.03 (7.74, 8.32)
65‐69 17.68 (17.46, 17.90) 2.42 (2.34, 2.49) 7.31 (7.07, 7.56)
70‐74 21.79 (21.52, 22.06) 3.32 (3.23, 3.42) 6.56 (6.35, 6.76)
75‐79 26.73 (26.39, 27.08) 4.63 (4.51, 4.76) 5.77 (5.60, 5.94)
80‐84 32.86 (32.37, 33.35) 6.89 (6.71, 7.06) 4.77 (4.63, 4.91)
85+ 34.47 (33.85, 35.10) 8.84 (8.63, 9.05) 3.90 (3.79, 4.02)
Gastric cardia cancer (GCC) 20‐24 0.04 (0.03, 0.05) 0.03 (0.02, 0.03) 1.49 (1.09, 2.02)
25‐29 0.08 (0.07, 0.09) 0.06 (0.05, 0.07) 1.32 (1.07, 1.62)
30‐34 0.23 (0.22, 0.25) 0.13 (0.11, 0.14) 1.85 (1.62, 2.12)
35‐39 0.52 (0.50, 0.55) 0.22 (0.20, 0.24) 2.41 (2.18, 2.66)
40‐44 1.11 (1.07, 1.15) 0.40 (0.38, 0.43) 2.76 (2.58, 2.96)
45‐49 2.28 (2.23, 2.34) 0.63 (0.60, 0.66) 3.62 (3.43, 3.82)
50‐54 4.16 (4.08, 4.24) 1.02 (0.98, 1.06) 4.08 (3.91, 4.26)
55‐59 7.25 (7.14, 7.37) 1.66 (1.60, 1.71) 4.38 (4.22, 4.53)
60‐64 10.96 (10.81, 11.12) 2.43 (2.36, 2.50) 4.51 (4.37, 4.65)
65‐69 15.70 (15.49, 15.91) 3.57 (3.48, 3.66) 4.40 (4.27, 4.53)
70‐74 20.28 (20.02, 20.55) 4.85 (4.74, 4.97) 4.18 (4.07, 4.30)
75‐79 23.79 (23.46, 24.12) 6.05 (5.91, 6.19) 3.93 (3.83, 4.04)
80‐84 25.21 (24.78, 25.65) 7.16 (6.98, 7.34) 3.52 (3.42, 3.63)
85+ 22.88 (22.38, 23.40) 6.98 (6.79, 7.17) 3.28 (3.17, 3.40)
Gastric noncardia cancer (GNCC) 20‐24 0.22 (0.20, 0.23) 0.30 (0.28, 0.32) 0.73 (0.65, 0.81)
25‐29 0.61 (0.58, 0.64) 0.86 (0.82, 0.90) 0.71 (0.67, 0.76)
30‐34 1.59 (1.54, 1.64) 2.03 (1.98, 2.09) 0.78 (0.75, 0.81)
35‐39 3.34 (3.27, 3.41) 3.38 (3.32, 3.46) 0.99 (0.96, 1.02)
40‐44 6.73 (6.63, 6.82) 5.28 (5.19, 5.37) 1.27 (1.25, 1.30)
45‐49 12.16 (12.03, 12.29) 7.49 (7.39, 7.60) 1.62 (1.59, 1.65)
50‐54 20.99 (20.81, 21.17) 10.28 (10.15, 10.40) 2.04 (2.01, 2.07)
55‐59 32.17 (31.93, 32.41) 13.80 (13.65, 13.96) 2.33 (2.30, 2.36)
60‐64 49.14 (48.81, 49.47) 19.93 (19.73, 20.13) 2.47 (2.44, 2.50)
65‐69 73.73 (73.28, 74.18) 31.04 (30.77, 31.32) 2.38 (2.35, 2.40)
70‐74 98.87 (98.28, 99.46) 43.87 (43.52, 44.22) 2.25 (2.23, 2.28)
75‐79 113.4 (112.7, 114.1) 53.56 (53.15, 53.99) 2.12 (2.10, 2.14)
80‐84 122.1 (121.1, 123.1) 60.86 (60.34, 61.38) 2.01 (1.98, 2.03)
85+ 119.7 (118.5, 120.9) 65.46 (64.89, 66.03) 1.83 (1.80, 1.85)